semaglutide fda approval date approves Ozempic® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease FDA Approves Wegovy Weight-Loss Pill

Grausland et al

Weight loss accounts for some improvement, but clinical trials show additional cholesterol and triglyceride reductions beyond what weight loss alone would predict

American Diabetes Association Diabetes Care

CBC reported that, depending on the dose, people can pay about $300 to $400, sometimes even more, per month for brand-name Ozempic [Source: cbc.ca/news/health/ozempic-semaglutide-generic-version-canada-9.7184915]

Your journey towards optimal health is unique, and at TrimRx, we are dedicated to being your trusted partner every step of the way

Patients on weight-loss jabs and diabetes injections should be aware there is a small risk of developing severe acute pancreatitis, the UK medicines regulator has said